LVTX insider transactions
LAVA Therapeutics N.V. (LVTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Get this as JSONLVTX insiders
Everyone who has filed a Form 3, 4, 5 or 144 at LAVA Therapeutics N.V., latest first. Follow anyone to get their next filing.
- Mary E. WadlingerDirector, since January 2025
- Fred M PowellChief Financial Officer, since January 2025
- Christy J. OligerDirector, since January 2025
- James NobleDirector, since January 2025
- Peter A KienerDirector, since January 2025
- Jay T. BackstromDirector, since January 2025
- Karen J WilsonDirector, since January 2025
- Kapil DhingraDirector, since January 2025
- Stephen A HurlyChief Executive Officer, Director, since January 2025
- Cooperatieve Gilde Healthcare IV U.A.10% owner, since January 2025-$5.14M
- Versant Venture Capital VI, L.P.10% owner, since January 2025-$6.57M
- Charles Q MorrisChief Medical Officer, since January 2025
Recent Form 3, 4, and 5 filings for LVTX
- Chief Financial Officer Powell Fred M returned 65,000 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Director Oliger Christy J.4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Director Wadlinger Mary E.4 - LAVA Therapeutics NV (0001840748) (Issuer)
- Director Wilson Karen J returned 10,000 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LAVA Therapeutics NV (0001840748) (Issuer)
- Director Dhingra Kapil returned 30,000 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Director Backstrom Jay T.4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Director Noble James4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Director Kiener Peter A4 - LAVA Therapeutics NV (0001840748) (Issuer)
- Chief Executive Officer Hurly Stephen A returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - LAVA Therapeutics NV (0001840748) (Issuer)
- Large owner Cooperatieve Gilde Healthcare Iv U.A. sold $4,224,719 worth of shares (2,871,370 units at $1.47) (SEC Form 4)4 - LAVA Therapeutics NV (0001840748) (Issuer)
- Large owner Cooperatieve Gilde Healthcare Iv U.A. sold $718,721 worth of shares (475,027 units at $1.51) (SEC Form 4)4 - LAVA Therapeutics NV (0001840748) (Issuer)
- Large owner Cooperatieve Gilde Healthcare Iv U.A. sold $197,898 worth of shares (126,992 units at $1.56) (SEC Form 4)4 - LAVA Therapeutics NV (0001840748) (Issuer)
- Large owner Versant Venture Capital Vi, L.P. sold $4,068,829 worth of shares (2,903,403 units at $1.40) (SEC Form 4)4 - LAVA Therapeutics NV (0001840748) (Issuer)
- Large owner Versant Venture Capital Vi, L.P. sold $2,502,261 worth of shares (1,684,434 units at $1.49) (SEC Form 4)4 - LAVA Therapeutics NV (0001840748) (Issuer)
- New insider Cooperatieve Gilde Healthcare Iv U.A. claimed ownership of 5,421,170 shares (SEC Form 3)3 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Director Wilson Karen J4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Director Backstrom Jay T.4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Director Kiener Peter A4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Director Noble James4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Director Wadlinger Mary E.4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Powell Fred M4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Director Dhingra Kapil4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Morris Charles Q4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Director Oliger Christy J.4 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Hurly Stephen A4 - LAVA Therapeutics NV (0001840748) (Issuer)
- New insider Versant Venture Capital Vi, L.P. claimed ownership of 4,587,837 shares (SEC Form 3)3 - LAVA Therapeutics NV (0001840748) (Issuer)
- New insider Wilson Karen J claimed ownership of 10,000 shares (SEC Form 3)3 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 3 filed by new insider Wadlinger Mary E.3 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 3 filed by new insider Oliger Christy J.3 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 3 filed by new insider Noble James3 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 3 filed by new insider Kiener Peter A3 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 3 filed by new insider Backstrom Jay T.3 - LAVA Therapeutics NV (0001840748) (Issuer)
- New insider Dhingra Kapil claimed ownership of 30,000 shares (SEC Form 3)3 - LAVA Therapeutics NV (0001840748) (Issuer)
- SEC Form 3 filed by new insider Morris Charles Q3 - LAVA Therapeutics NV (0001840748) (Issuer)
- New insider Powell Fred M claimed ownership of 65,000 shares (SEC Form 3)3 - LAVA Therapeutics NV (0001840748) (Issuer)
- New insider Hurly Stephen A claimed ownership of 5,000 shares (SEC Form 3)3 - LAVA Therapeutics NV (0001840748) (Issuer)